Zavedos (idarubicin)

27.11.2013 Updated 22.10.2019 5170 views

By MoH Order No. 991 of 20.11.13, the instructions for medical use (hereinafter, the instructions) of the original (reference) medicinal product containing idarubicin, namely the medicinal product Zavedos, lyophilisate for solution for infusion, were approved with amendments and additions to the following sections of the instructions: “Contraindications”, “Adverse reactions”, “Special warnings and precautions for use”, “Overdose”, “Interaction with other medicinal products and other forms of interaction”.

Other materials in this section